Product logins

Find logins to all Clarivate products below.


Laparoscopic Surgical Robotic Devices | Market Insights | Global | 2021

In 2020, the global laparoscopic surgical robotic device market will be severely impacted by the COVID-19 pandemic but will nevertheless still grow strongly through 2029. This will be driven by rising robotic-assisted procedure volumes, growing demand for minimally invasive surgery, increasing acceptance and adoption of surgical robotic technology, the launch of new and innovative robotic systems, and an increase in clinical evidence that supports the benefits of robotic surgery.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic surgical robotic devices in the US, Europe, and the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Pulmonology Devices | Market Insights | US | 2021
​In 2020, the US pulmonology device market will be moderately impacted by the COVID-19 pandemic but will nevertheless grow over the forecast period, fueled by bronchoscopy procedure volume…
Report
Neurovascular Devices | Market Insights | US | 2021
The COVID-19 pandemic will have a modest impact on the US market for neurovascular devices in the short term. Once the impact subsides, adoption of innovative devices as well as the ongoing…
Report
Interventional Oncology Devices | Market Insights | US | 2021
Despite the short-term challenges posed by the COVID-19 pandemic, the US market for interventional oncology devices will grow modestly through 2029. This will be driven largely by the…
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | US | 2021
Following the initial impact of the COVID-19 pandemic, the US market for TEO devices will expand at a moderate rate. Market growth will be driven by continual product innovations and the…
Report
Biosurgical Agents | Market Insights | Latin America | 2021
Although it will be negatively impacted in the short term by the COVID-19 pandemic, the biosurgical agent market in Latin America will grow at a modest rate through 2029, primarily driven by …